Down-regulation of the global regulator SATB1 by statins in COLO205 colon cancer cells

Lakshminarayana Reddy, C. N. ; Vyjayanti, V. N. ; Notani, Dimple ; Galande, Sanjeev ; Kotamraju, Srigiridhar (2010) Down-regulation of the global regulator SATB1 by statins in COLO205 colon cancer cells Molecular Medicine Reports, 3 (5). pp. 857-861. ISSN 1791-2997

PDF - Publisher Version

Official URL:

Related URL:


Special AT-rich sequence binding protein 1 (SATB1) regulates the expression of more than 1,000 genes in tumor cells. SATB1 expression has been implicated in metastasis, and its silencing results in reduced cancer progression and the reversion of metastatic cells to normal appearance. Therefore, any compound causing down-regulation of SATB1 expression or activity may be exploited for its therapeutic potential in terms of cancer regression. Earlier studies showed that the 3-hydroxy-3-methylglutaryl coenzymeA (HMG-CoA) reductase inhibitors (statin drugs), which are widely used to treat hypercholesterolemia, possess other pleotropic activities. These are now increasingly gaining attention for their cancer prevention abilities. However, the downstream interplay of the molecular mechanisms of such anti-cancer activities is unclear. Here, we show that SATB1 is down-regulated by statins in a time- and dose-dependent manner in COLO205 cells. This effect was statin-specific as the down-regulation of SATB1 was brought about by hydrophobic statins, such as simvastatin and fluvastatin, but not by hydrophilic pravastatin. Notably, treatment with mevalonate, an intermediate in the cholesterol and isoprenoid biosynthetic pathways, led to the inhibition of SATB1 down-regulation and cytotoxicity mediated by statins. Treatment with the proteasome inhibitors lactacystine and MG-132 inhibited the statin-mediated down-regulation of SATB1, suggesting that regulation occurs at the post-translational level. Thus, our results demonstrate a novel molecular mechanism for the anti-cancer activity of statin drugs in colon cancer cells, without invoking significant cytotoxicity.

Item Type:Article
Source:Copyright of this article belongs to Spandidos Publications Ltd.
Keywords:Special AT-rich Sequence Binding Protein 1; Statins; Isoprenylation; COLO205 Cells; Cancer
ID Code:67810
Deposited On:02 Nov 2011 10:20
Last Modified:18 May 2016 14:46

Repository Staff Only: item control page